Literature DB >> 3549283

Suppression of defective RAS1 and RAS2 functions in yeast by an adenylate cyclase activated by a single amino acid change.

E De Vendittis, A Vitelli, R Zahn, O Fasano.   

Abstract

We have constructed the yeast strain TS1, with the RAS2 gene replaced by mutant allele encoding a partially defective gene product, and with an inactive RAS1 gene. TS1 cells accumulate as unbudded cells upon temperature shift from 30 to 37 degrees C, thus showing that the RAS1 and RAS2 gene functions are important for progression through the G1 phase of the cell cycle. After the isolation of revertants able to grow at the nonpermissive temperature, we have found that a chromosomal point mutation can bypass the G1 arrest of TS1 and cdc25 cells, and the lethality of ras1 ras2 mutants. The mutation predicts the replacement of threonine by isoleucine at position 1651 of yeast adenylate cyclase. The RAS-independent, as well as the RAS-dependent adenylate cyclase activity, is increased by the mutation. Like the wild-type enzyme, the RAS-dependent activity of the mutant adenylate cyclase is turned on by the GTP-bound form of the RAS2 protein. The amino acid sequence surrounding the threonine 1651 shows similarity with protein kinase substrates. Possible implications for the function of adenylate cyclase are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3549283      PMCID: PMC1167407          DOI: 10.1002/j.1460-2075.1986.tb04696.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  21 in total

Review 1.  Phosphorylation-dephosphorylation of enzymes.

Authors:  E G Krebs; J A Beavo
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

2.  Transformation in yeast: development of a hybrid cloning vector and isolation of the CAN1 gene.

Authors:  J R Broach; J N Strathern; J B Hicks
Journal:  Gene       Date:  1979-12       Impact factor: 3.688

3.  Construction of a colicin E1-R factor composite plasmid in vitro: means for amplification of deoxyribonucleic acid.

Authors:  T Tanaka; B Weisblum
Journal:  J Bacteriol       Date:  1975-01       Impact factor: 3.490

4.  New human transforming genes detected by a tumorigenicity assay.

Authors:  O Fasano; D Birnbaum; L Edlund; J Fogh; M Wigler
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

5.  Identification of the structural gene and nonsense alleles for adenylate cyclase in Saccharomyces cerevisiae.

Authors:  K Matsumoto; I Uno; T Ishikawa
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

6.  Functional homology of mammalian and yeast RAS genes.

Authors:  T Kataoka; S Powers; S Cameron; O Fasano; M Goldfarb; J Broach; M Wigler
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

7.  In yeast, RAS proteins are controlling elements of adenylate cyclase.

Authors:  T Toda; I Uno; T Ishikawa; S Powers; T Kataoka; D Broek; S Cameron; J Broach; K Matsumoto; M Wigler
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

8.  Genetic analysis of yeast RAS1 and RAS2 genes.

Authors:  T Kataoka; S Powers; C McGill; O Fasano; J Strathern; J Broach; M Wigler
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

9.  Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane.

Authors:  T Hunter; N Ling; J A Cooper
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

10.  Yeast transformation: a model system for the study of recombination.

Authors:  T L Orr-Weaver; J W Szostak; R J Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  31 in total

1.  Isolation and characterization of temperature-sensitive mutations in the RAS2 and CYR1 genes of Saccharomyces cerevisiae.

Authors:  H Mitsuzawa; I Uno; T Oshima; T Ishikawa
Journal:  Genetics       Date:  1989-12       Impact factor: 4.562

2.  Mutational mapping of RAS-responsive domains of the Saccharomyces cerevisiae adenylyl cyclase.

Authors:  J Colicelli; J Field; R Ballester; N Chester; D Young; M Wigler
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

3.  Site-directed mutagenesis of the Saccharomyces cerevisiae CDC25 gene: effects on mitotic growth and cAMP signalling.

Authors:  C Schomerus; T Munder; H Küntzel
Journal:  Mol Gen Genet       Date:  1990-09

4.  Antibodies to synthetic peptide from the residue 33 to 42 domain of c-Ha-ras p21 block reconstitution of the protein with different effectors.

Authors:  I Rey; P Soubigou; L Debussche; C David; A Morgat; P E Bost; J F Mayaux; B Tocque
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

5.  Transcriptional regulatory elements of the RAS2 gene of Saccharomyces cerevisiae.

Authors:  J Lisziewicz; J Brown; D Breviario; T Sreenath; N Ahmed; R Koller; R Dhar
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

6.  Regulation of respiratory growth by Ras: the glyoxylate cycle mutant, cit2Delta, is suppressed by RAS2.

Authors:  Jan H Swiegers; Isak S Pretorius; Florian F Bauer
Journal:  Curr Genet       Date:  2006-07-11       Impact factor: 3.886

7.  Cyclic AMP-independent regulation of protein kinase A substrate phosphorylation by Kelch repeat proteins.

Authors:  Ailan Lu; Jeanne P Hirsch
Journal:  Eukaryot Cell       Date:  2005-11

8.  The PDE1-encoded low-affinity phosphodiesterase in the yeast Saccharomyces cerevisiae has a specific function in controlling agonist-induced cAMP signaling.

Authors:  P Ma; S Wera; P Van Dijck; J M Thevelein
Journal:  Mol Biol Cell       Date:  1999-01       Impact factor: 4.138

9.  Efficient transition to growth on fermentable carbon sources in Saccharomyces cerevisiae requires signaling through the Ras pathway.

Authors:  Y Jiang; C Davis; J R Broach
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

10.  Identification of amino acid residues required for Ras p21 target activation.

Authors:  M S Marshall; L J Davis; R D Keys; S D Mosser; W S Hill; E M Scolnick; J B Gibbs
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.